Advertisement
Screener

REPLIGEN CORP (RGEN) Increase (Decrease) in Inventories

2.8 / 5 stars · 68/120 Roast Me

REPLIGEN CORP Increase (Decrease) in Inventories

REPLIGEN CORP (RGEN) reported Increase (Decrease) in Inventories of $20.16 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInInventories · last filed 2026-07-29

  • REPLIGEN CORP increase (decrease) in inventories for the quarter ending 2026-06-30 was $8.09M.
  • REPLIGEN CORP increase (decrease) in inventories for the quarter ending 2026-03-31 was $12.07M, a 215.28% increase year-over-year.
  • REPLIGEN CORP increase (decrease) in inventories for the quarter ending 2025-12-31 was $9.60M.
  • REPLIGEN CORP increase (decrease) in inventories for the quarter ending 2025-09-30 was $4.52M.
  • REPLIGEN CORP increase (decrease) in inventories for fiscal 2025 was $14.95M.
  • REPLIGEN CORP increase (decrease) in inventories for fiscal 2024 was -$56.90M.
  • REPLIGEN CORP increase (decrease) in inventories for fiscal 2023 was -$40.97M, a 171.63% decline from fiscal 2022.
  • REPLIGEN CORP increase (decrease) in inventories for fiscal 2022 was $57.20M, a 36.28% decline from fiscal 2021.
Period endIncrease (Decrease) in Inventories 3 monthIncrease (Decrease) in Inventories 3 month as first filedIncrease (Decrease) in Inventories 6 monthIncrease (Decrease) in Inventories 6 month as first filedIncrease (Decrease) in Inventories 9 monthIncrease (Decrease) in Inventories 9 month as first filedIncrease (Decrease) in Inventories 12 monthIncrease (Decrease) in Inventories 12 month as first filed
2026-06-30$8.09M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29
$20.16M
10-Q · filed 2026-07-29
$29.76M
derived: sum of 3 quarters · filed 2026-07-29
$34.28M
derived: sum of 4 quarters · filed 2026-07-29
2026-03-31$12.07M
10-Q · filed 2026-05-06
$21.67M
derived: sum of 2 quarters · filed 2026-05-06
$26.19M
derived: sum of 3 quarters · filed 2026-05-06
$23.19M
derived: sum of 4 quarters · filed 2026-07-29
2025-12-31$9.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$14.12M
derived: sum of 2 quarters · filed 2026-02-26
$11.12M
derived: sum of 3 quarters · filed 2026-07-29
$14.95M
10-K · filed 2026-02-26
2025-09-30$4.52M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$1.52M
derived: sum of 2 quarters · filed 2026-07-29
$5.35M
10-Q · filed 2025-11-04
-$31.42M
derived: sum of 4 quarters · filed 2026-07-29
2025-06-30-$3.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29
$824.00K
10-Q · filed 2026-07-29
-$35.94M
derived: sum of 3 quarters · filed 2026-07-29
-$45.60M
derived: sum of 4 quarters · filed 2026-07-29
2025-03-31$3.83M
10-Q · filed 2026-05-06
-$32.94M
derived: sum of 2 quarters · filed 2026-05-06
-$42.59M
derived: sum of 3 quarters · filed 2026-05-06
-$49.90M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31-$36.76M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$46.42M
derived: sum of 2 quarters · filed 2026-02-26
-$53.73M
derived: sum of 3 quarters · filed 2026-02-26
-$56.90M
10-K · filed 2026-02-26
2024-09-30-$9.66M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
-$16.96M
derived: sum of 2 quarters · filed 2025-11-04
-$20.13M
10-Q · filed 2025-11-04
-$35.13M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30-$7.31M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
-$10.47M
10-Q · filed 2025-08-07
-$25.47M
derived: sum of 3 quarters · filed 2026-02-26
-$53.95M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31-$3.17M
10-Q · filed 2025-04-29
-$18.16M
derived: sum of 2 quarters · filed 2026-02-26
-$46.65M
derived: sum of 3 quarters · filed 2026-02-26
-$49.98M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31-$14.99M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-02-26
-$43.48M
derived: sum of 2 quarters · filed 2026-02-26
-$46.82M
derived: sum of 3 quarters · filed 2026-02-26
-$40.97M
10-K · filed 2026-02-26
2023-09-30-$28.49M
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2024-11-18
-$31.82M
derived: sum of 2 quarters · filed 2024-11-18
-$25.98M
10-Q/A · filed 2024-11-18
-$33.08M
derived: sum of 4 quarters · filed 2025-03-14
2023-06-30-$3.34M
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-11-18
$2.51M
10-Q/A · filed 2024-11-18
-$4.60M
derived: sum of 3 quarters · filed 2025-03-14
$1.61M
derived: sum of 4 quarters · filed 2025-03-14
2023-03-31$5.84M
10-Q/A · filed 2024-11-18
-$1.26M
derived: sum of 2 quarters · filed 2025-03-14
$4.94M
derived: sum of 3 quarters · filed 2025-03-14
$33.01M
derived: sum of 4 quarters · filed 2025-03-14
2022-12-31-$7.10M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-03-14
-$902.00K
derived: sum of 2 quarters · filed 2025-03-14
$27.17M
derived: sum of 3 quarters · filed 2025-03-14
$57.20M
10-K · filed 2025-03-14
2022-09-30$6.20M
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2024-11-18
$34.27M
derived: sum of 2 quarters · filed 2024-11-18
$64.31M
10-Q/A · filed 2024-11-18
$92.49M
derived: sum of 4 quarters · filed 2024-11-18
2022-06-30$28.07M
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-11-18
$58.11M
10-Q/A · filed 2024-11-18
$86.29M
derived: sum of 3 quarters · filed 2024-11-18
$105.11M
derived: sum of 4 quarters · filed 2024-11-18
2022-03-31$30.04M
10-Q/A · filed 2024-11-18
$58.22M
derived: sum of 2 quarters · filed 2024-11-18
$77.05M
derived: sum of 3 quarters · filed 2024-11-18
$102.79M
derived: sum of 4 quarters · filed 2024-11-18
2021-12-31$28.18M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-11-18
$47.01M
derived: sum of 2 quarters · filed 2024-11-18
$72.76M
derived: sum of 3 quarters · filed 2024-11-18
$89.78M
10-K/A · filed 2024-11-18
2021-09-30$18.82M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01
$44.57M
derived: sum of 2 quarters · filed 2022-11-01
$61.60M
10-Q · filed 2022-11-01
$68.83M
derived: sum of 4 quarters · filed 2023-02-22
2021-06-30$25.75M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02
$42.77M
10-Q · filed 2022-08-02
$50.00M
derived: sum of 3 quarters · filed 2023-02-22
$57.80M
derived: sum of 4 quarters · filed 2023-02-22
2021-03-31$17.02M
10-Q · filed 2022-04-27
$24.25M
derived: sum of 2 quarters · filed 2023-02-22
$32.05M
derived: sum of 3 quarters · filed 2023-02-22
$39.83M
derived: sum of 4 quarters · filed 2023-02-22
2020-12-31$7.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22
$15.03M
derived: sum of 2 quarters · filed 2023-02-22
$22.80M
derived: sum of 3 quarters · filed 2023-02-22
$29.99M
10-K · filed 2023-02-22
$29.26M
10-K · filed 2021-02-24
2020-09-30$7.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28
$15.58M
derived: sum of 2 quarters · filed 2021-10-28
$22.77M
10-Q · filed 2021-10-28
$28.67M
derived: sum of 4 quarters · filed 2022-02-17
2020-06-30$7.77M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-27
$14.96M
10-Q · filed 2021-07-27
$20.87M
derived: sum of 3 quarters · filed 2022-02-17
$21.62M
derived: sum of 4 quarters · filed 2022-02-17
2020-03-31$7.19M
10-Q · filed 2021-05-04
$13.10M
derived: sum of 2 quarters · filed 2022-02-17
$13.85M
derived: sum of 3 quarters · filed 2022-02-17
$16.51M
derived: sum of 4 quarters · filed 2022-02-17
2019-12-31$5.91M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17
$6.66M
derived: sum of 2 quarters · filed 2022-02-17
$9.32M
derived: sum of 3 quarters · filed 2022-02-17
$10.80M
10-K · filed 2022-02-17
$9.31M
10-K · filed 2020-02-26
2019-09-30$754.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$3.41M
derived: sum of 2 quarters · filed 2020-11-05
$4.89M
10-Q · filed 2020-11-05
$4.13M
derived: sum of 4 quarters · filed 2021-02-24
2019-06-30$2.66M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30
$4.14M
10-Q · filed 2020-07-30
$3.37M
derived: sum of 3 quarters · filed 2021-02-24
$5.08M
derived: sum of 4 quarters · filed 2021-02-24
2019-03-31$1.48M
10-Q · filed 2020-05-06
$715.00K
derived: sum of 2 quarters · filed 2021-02-24
$2.42M
derived: sum of 3 quarters · filed 2021-02-24
$4.33M
derived: sum of 4 quarters · filed 2021-02-24
2018-12-31-$763.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24
$946.00K
derived: sum of 2 quarters · filed 2021-02-24
$2.85M
derived: sum of 3 quarters · filed 2021-02-24
$4.04M
10-K · filed 2021-02-24
2018-09-30$1.71M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31
$3.62M
derived: sum of 2 quarters · filed 2019-10-31
$4.80M
10-Q · filed 2019-10-31
$4.90M
derived: sum of 4 quarters · filed 2020-02-26
2018-06-30$1.91M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01
$3.10M
10-Q · filed 2019-08-01
$3.19M
derived: sum of 3 quarters · filed 2020-02-26
$1.68M
derived: sum of 4 quarters · filed 2020-02-26
2018-03-31$1.19M
10-Q · filed 2019-05-09
$1.28M
derived: sum of 2 quarters · filed 2020-02-26
-$230.00K
derived: sum of 3 quarters · filed 2020-02-26
$1.43M
derived: sum of 4 quarters · filed 2020-02-26
2017-12-31$94.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26
-$1.42M
derived: sum of 2 quarters · filed 2020-02-26
$246.00K
derived: sum of 3 quarters · filed 2020-02-26
-$605.00K
10-K · filed 2020-02-26
2017-09-30-$1.51M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01
$152.00K
derived: sum of 2 quarters · filed 2018-11-01
-$699.00K
10-Q · filed 2018-11-01
-$993.00K
derived: sum of 4 quarters · filed 2019-03-01
2017-06-30$1.66M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02
$813.00K
10-Q · filed 2018-08-02
$519.00K
derived: sum of 3 quarters · filed 2019-03-01
$1.88M
derived: sum of 4 quarters · filed 2019-03-01
2017-03-31-$851.00K
10-Q · filed 2018-05-08
-$1.15M
derived: sum of 2 quarters · filed 2019-03-01
$219.00K
derived: sum of 3 quarters · filed 2019-03-01
$2.22M
derived: sum of 4 quarters · filed 2019-03-01
2016-12-31-$294.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01
$1.07M
derived: sum of 2 quarters · filed 2019-03-01
$3.07M
derived: sum of 3 quarters · filed 2019-03-01
$6.16M
10-K · filed 2019-03-01
2016-09-30$1.36M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$3.37M
derived: sum of 2 quarters · filed 2017-11-09
$6.46M
10-Q · filed 2017-11-09
$8.55M
derived: sum of 4 quarters · filed 2018-02-22
2016-06-30$2.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03
$5.09M
10-Q · filed 2017-08-03
$7.19M
derived: sum of 3 quarters · filed 2018-02-22
$8.86M
derived: sum of 4 quarters · filed 2018-02-22
2016-03-31$3.09M
10-Q · filed 2017-05-04
$5.19M
derived: sum of 2 quarters · filed 2018-02-22
$6.86M
derived: sum of 3 quarters · filed 2018-02-22
$8.73M
derived: sum of 4 quarters · filed 2018-02-22
2015-12-31$2.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22
$3.77M
derived: sum of 2 quarters · filed 2018-02-22
$5.63M
derived: sum of 3 quarters · filed 2018-02-22
$6.15M
10-K · filed 2018-02-22
2015-09-30$1.67M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
$3.54M
derived: sum of 2 quarters · filed 2016-11-03
$4.05M
10-Q · filed 2016-11-03
$3.56M
derived: sum of 4 quarters · filed 2017-02-23
2015-06-30$1.87M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
$2.38M
10-Q · filed 2016-08-04
$2.38M
10-Q · filed 2015-08-06
$1.89M
derived: sum of 3 quarters · filed 2017-02-23
$2.95M
derived: sum of 4 quarters · filed 2017-02-23
2015-03-31$514.00K
10-Q · filed 2016-05-05
$513.64K
10-Q · filed 2015-05-08
$27.00K
derived: sum of 2 quarters · filed 2017-02-23
$1.09M
derived: sum of 3 quarters · filed 2017-02-23
$1.71M
derived: sum of 4 quarters · filed 2017-02-23
2014-12-31-$487.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23
$573.74K
derived: sum of 2 quarters · filed 2017-02-23
$1.19M
derived: sum of 3 quarters · filed 2017-02-23
$860.00K
10-K · filed 2017-02-23
$860.12K
10-K · filed 2015-03-17
2014-09-30$1.06M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
$1.68M
derived: sum of 2 quarters · filed 2015-11-05
$1.35M
10-Q · filed 2015-11-05
$1.35M
10-Q · filed 2014-11-07
$3.12M
derived: sum of 4 quarters · filed 2016-02-25
2014-06-30$617.35K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$286.26K
10-Q · filed 2015-08-06
$2.06M
derived: sum of 3 quarters · filed 2016-02-25
$1.27M
derived: sum of 4 quarters · filed 2016-02-25
2014-03-31-$331.09K
10-Q · filed 2015-05-08
$1.44M
derived: sum of 2 quarters · filed 2016-02-25
$655.78K
derived: sum of 3 quarters · filed 2016-02-25
$1.17M
derived: sum of 4 quarters · filed 2016-02-25
2013-12-31$1.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25
$986.87K
derived: sum of 2 quarters · filed 2016-02-25
$1.50M
derived: sum of 3 quarters · filed 2016-02-25
$626.00K
10-K · filed 2016-02-25
$625.89K
10-K · filed 2014-03-14
2013-09-30-$789.13K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07
-$277.74K
derived: sum of 2 quarters · filed 2014-11-07
-$1.15M
10-Q · filed 2014-11-07
-$848.18K
derived: sum of 4 quarters · filed 2015-03-17
2013-06-30$511.39K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11
-$360.87K
10-Q · filed 2014-08-11
-$59.06K
derived: sum of 3 quarters · filed 2015-03-17
-$1.44M
derived: sum of 4 quarters · filed 2015-03-17
2013-03-31-$872.26K
10-Q · filed 2014-05-09
-$570.45K
derived: sum of 2 quarters · filed 2015-03-17
-$1.95M
derived: sum of 3 quarters · filed 2015-03-17
-$3.66M
derived: sum of 4 quarters · filed 2015-03-17
2012-12-31$301.81K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-17
-$1.08M
derived: sum of 2 quarters · filed 2015-03-17
-$2.79M
derived: sum of 3 quarters · filed 2015-03-17
-$2.73M
10-K · filed 2015-03-17
2012-09-30-$1.38M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08
-$3.09M
derived: sum of 2 quarters · filed 2013-11-08
-$3.04M
10-Q · filed 2013-11-08
-$2.67M
derived: sum of 4 quarters · filed 2014-03-14
2012-06-30-$1.71M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07
-$1.66M
10-Q · filed 2013-08-07
-$1.29M
derived: sum of 3 quarters · filed 2014-03-14
-$1.53M
derived: sum of 4 quarters · filed 2014-03-14
2012-03-31$54.78K
10-Q · filed 2013-05-07
$418.93K
derived: sum of 2 quarters · filed 2014-03-14
$186.22K
derived: sum of 3 quarters · filed 2014-03-14
$925.03K
derived: sum of 4 quarters · filed 2014-03-14
2011-12-31$364.14K
derived: 10-K 9 month − 10-Q 6 month · filed 2014-03-14
$131.44K
derived: sum of 2 quarters · filed 2014-03-14
$870.25K
10-K · filed 2014-03-14
$886.66K
derived: sum of 4 quarters · filed 2014-03-14
2011-09-30-$232.70K
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-11-09
$506.11K
10-Q · filed 2011-11-09
$522.51K
10-Q · filed 2012-11-08
$423.22K
derived: sum of 4 quarters · filed 2014-03-14
2011-06-30$738.81K
10-Q · filed 2011-08-05
$755.22K
10-Q · filed 2012-08-09
$655.93K
derived: sum of 3 quarters · filed 2014-03-14
$474.11K
derived: sum of 4 quarters · filed 2014-03-14
2011-03-31$16.41K
10-Q · filed 2012-05-10
-$82.89K
derived: sum of 2 quarters · filed 2014-03-14
-$264.70K
derived: sum of 3 quarters · filed 2014-03-14
-$247.16K
10-K · filed 2013-03-15
2010-12-31-$99.29K
derived: 10-K 9 month − 10-Q 6 month · filed 2014-03-14
-$281.11K
derived: sum of 2 quarters · filed 2014-03-14
-$263.57K
10-K · filed 2014-03-14
2010-09-30-$181.81K
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-11-09
-$164.28K
10-Q · filed 2011-11-09
2010-06-30$17.54K
10-Q · filed 2011-08-05
2010-03-31-$212.09K
10-K · filed 2012-03-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
BIO-TECHNE Corp (TECH)United States$11.379B74.68
Twist Bioscience Corp (TWST)United States$11.540B-47.21
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
EXELIXIS, INC. (EXEL)United States$14.358B16.15
Immunovant, Inc. (IMVT)United States$7.028B-14.78